Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 149   

Articles published

NVS 104.25 +0.72 (0.70%)
price chart
General Report on Novartis AG (ADR) (NYSE:NVS)
[Reuters] Novartis AG (ADR) (NYSE:NVS)(TREND ANALYSIS) Swiss drugmaker Novartis is raising its bet on smart technology by collaborating with U.S.
Novartis AG Sets Foot In “Robotic Pill” Space; Joins Hands With Rani Therapeutics
Novartis AG (ADR) (NYSE:NVS) announced Tuesday it will be collaborating with California-based startup Rani Therapeutics to benefit from its novel oral biotherapeutics drug delivery platform.
Novartis AG (ADR) Partners With Aduro Biotech With A $750 Million Deal
Novartis AG (ADR) (NYSE:NVS) has announced a deal with cancer immunotherapy company, Aduro Biotech, Inc., in which both the companies will partner to research and manufacture treatments for cancer.
Novartis AG (ADR) Inks $750 Million Deal With Aduro Biotech  Bidness ETC
Technical Insights on Novartis AG (ADR) (NYSE:NVS)
[Bloomberg] Novartis AG (ADR) (NYSE:NVS)(TREND ANALYSIS) the world's biggest drugmaker by sales, reported first-quarter profit that beat analysts' estimates as the company begins to benefit from a set of transactions that make it smaller and more ...
Novartis AG (ADR) (NVS) Seeks $2-5 Billion Takeover Targets  Bidness ETC
Novartis AG's (ADR) (NYSE:NVS) (ADR) Looking For Buyout in the Range of ...  WallStreetPR (blog)
Driven By Pfizer Inc. And Novartis AG (ADR), Global Breast Cancer Drug Sales ...
New breast cancer drugs from Novartis AG (ADR) (NYSE:NVS) can add another $5 billion to global sales for the disease in 2020.
Stock To Watch : Novartis AG (ADR)(NYSE:NVS)
Novartis AG (ADR)(NYSE:NVS) (TREND ANALYSIS) shares are still trading near the 52-week high of $102.59. The stock closed last trading session at $101.48, with a volume of 1,334,174 shares against an average volume for the last 3 months of 1,498,780.
Gender Discrimination Lawsuit Filed Against Novartis AG (ADR)(NYSE:NVS)
There are various allegations of Sexual discrimination against Novartis AG (ADR) (NYSE:NVS)and it will have to defend itself against them in US courts.
Novartis AG (ADR) Biosimilar Blocked By US Appeals Court
The US Appeals court has blocked Novartis AG (ADR) (NYSE:NVS) from selling a copy of Amgen, Inc.'s (NASDAQ:AMGN) cancer supportive-care drug in the US for an indefinite period of time - or at least until June 3, when verbal arguments are scheduled, ...
Pharma's Record Setting First Quarter [Actavis plc, Allergan, Inc., Eli Lilly ...
Some major deals have contributed to that record-breaking total. In March, AbbVie Inc. (NYSE: ABBV) announced the purchase of Pharmacyclics Inc.(Nasdaq: PCYC) for $21 billion.
Johnson & Johnson (JNJ), Gilead Sciences, Inc. (GILD) and Novartis AG (ADR ...
The stake in Novartis AG (ADR) (NYSE:NVS) increased to 63,268 shares in 1Q from 59,083 shares in 4Q. The new stake was worth $6.2 million at the end of the latest quarter, representing a decent improvement in dollar value from $5.5 million in the ...